-
A 12-month, 2-arm, 2-period, randomized, controlled trial of a digital solution for the management of Parkinson’s disease (PD): Rationale and study design
-
A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery
-
A case of misdiagnosed Parkinson’s disease (PD)
-
A case of PD with non -motor symptoms onset
-
A case of thalamic malignant glioma formation in a patient with STN-DBS for Parkinson’s disease
-
A case series of sigmoid volvulus in Parkinson’s disease
-
A case with posttraumatic functional shoulder dyskinesia
-
A clinical trials ‘charter’ to improve communication about, recruitment to and retention in Parkinson’s clinical trials
-
A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)
-
A cognitive fMRI study of non-manifesting LRRK2 and GBA carriers
-
A cognitive monitoring program for individuals with Parkinson’s disease submitted to deep brain stimulation
-
A combined therapeutic approach in the management of abnormal postures in Parkinson’s disease
-
A community organizing approach to identify and address the barriers to healthcare for XDP patients in Panay Island, Philippines
-
A comparative study of clinical profile of patients of drug induced parkinsonism with idiopathic Parkinson’s disease
-
A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study
-
A comparison of self-report and performance-based balance measures to predict recurrent falls in people with Parkinson’s disease: A cohort study
-
A comparison of standards of care in Parkinson’s disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines
-
A comparison study of health-related quality of life between female and male patients with Parkinson’s disease
-
A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease
-
A computational model of iron transport between the blood circulation and the brain
-
A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson’s disease (The ACCORD-PD study)
-
A cross-linguistic approach to speech intelligibility in people with PD
-
A cross-sectional study in spinocerebellar ataxia type 12 (SCA-12) patients from a tertiary care center in Eastern India
-
A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders
-
A crossover study of pretarsal and preseptal injections of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm and blepharospasm
-
A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series
-
A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease
-
A double blind investigation of efficacy and safety of incobotulinumtoxinA in Parkinson’s disease tremor- A customized injection approach
-
A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease
-
A dynamic causal model of the superior colliculus: Inhibitory activity increases with the temporal discrimination threshold
-
A functional magnetic imaging study of the response in the superior colliculus to looming stimuli in cervical dystonia patients and their relatives
-
A health cost analysis for Huntington disease in Peru
-
A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)
-
A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17
-
A heterozygous splicing variant in NPC2 in a patient with PSP
-
A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V)
-
A largest case series study of spinocerebellar ataxia type 2(SCA2) from India: Do SCA2 clinical subtypes exists?
-
A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project
-
A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease
-
A multi-centre European comparative survey of advanced therapies (infusion and deep brain stimulation) in Parkinson’s disease
-
A multi-site survey of Parkinson’s disease deep brain stimulation center best practice: moving toward a standard of care for DBS
-
A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences
-
A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test
-
A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)
-
A new tool to stage Parkinson’s disease PDCS (Parkinson’s disease composite scale): A pilot study on behalf of the European Parkinson’s disease association (EPDA)
-
A novel C. elegans model for identification of small molecules that target alpha-synuclein-mediated toxicity
-
A novel causal mutation for spinocerebellar ataxia 19/22 (SCA19)
-
A novel haplotype in LRRK2 is associated with risk for multiple system atrophy in the Korean population
-
A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family
-
A novel interdisciplinary palliative care clinic for advanced Parkinson’s disease and Parkinsonian syndromes
-
A novel phenotype associated with GRN mutations: Spastic ataxia
-
A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)
-
A novel single molecule imaging approach to detect individual protein oligomers in CSF from patients with Parkinson’s disease (PD)
-
A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy
-
A phase 3, placebo-controlled study with an open-label extension: Sustained incobotulinumtoxinA efficacy in upper-limb post-stroke spasticity over 48 weeks
-
A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Feasibility and safety
-
A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Signal of efficacy
-
A pilot study of horizontal current steering with chronically implanted segmented electrodes for STN-DBS in Parkinson’s disease
-
A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome
-
A pilot study of whole exome sequencing in progressive supranuclear palsy
-
A polysomnography study of REM sleep without atonia and REM sleep behavior disorder in MSA and PD
-
A proposed Parkinson’s disease neuropsychological battery (PNB)
-
A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease
-
A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)
-
A randomized controlled clinical study to evaluate efficacy, safety and tolerability of SC L-dopa/carbidopa (ND0612H) infusion regimens in fluctuating PD patients
-
A randomized double-blind placebo- and positive-controlled crossover study to evaluate the effects of single doses of SD-809 (deutetrabenazine) and tetrabenazine on the corrected QT interval
-
A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)
-
A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans
-
A rare genetic transcriptomopathy syndrome involving TAF1 leading to insights into more common neurologic disorders, including X-linked dystonia-parkinsonism (XDP)
-
A step forward to the future: UPDRS kinematic measures for telemedicine
-
A strategy to classify Parkinson’s disease patients with dyskinesia: The analysis of center of pressure with impact of cognitive loading
-
A study to assess the quality of life and strain in caregivers of people with Parkinson’s disease in India
-
A survey of impulse control disorders in Chinese patients with Parkinson’s disease and literature review
-
A survey of movement disorders in a large sample of patients treated with antipsychotic medication
-
A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability
-
A unique phenotype associated with anti-GAD antibodies
-
A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease
-
A web resource on levodopa-induced dyskinesia (LID) genetics
-
A whole brain anatomical network model and its application in PD research
-
Abnormal findings in polisomnographic records of patients with spinocerebellar ataxia type 2 (SCA2)
-
Abnormal intrinsic brain activity reveals neural correlates of impaired cognitive function in early stage of Huntington’s disease (HD): A resting-state fMRI study
-
Abnormal motor sequence representation in dystonia
-
AbobotulinumtoxinA for cervical dystonia: A meta-analysis of injection practices across 5 countries
-
AbobotulinumtoxinA for cervical dystonia: International treatment patterns
-
Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis
-
Accuracy of intraoperative CT during DBS procedures: Comparison with postoperative MRI
-
Active movement discrimination of the ankle in Parkinson’s disease
-
Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson’s disease patients treated with opicapone
-
Acute admissions in people with Parkinson’s – More than just frailty
-
Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report
-
Acute movement disorders in Tunisian childhood
-
ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families
-
Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease
-
ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study
-
Adult onset Niemann-Pick type C: 24 month follow-up on miglustat
-
Affective theory of mind in Parkinson’s disease
-
Age associated effects of levodopa administration on striatal acetylcholinesterase activity
-
Airway protective mechanisms and deep brain stimulation in Parkinson’s disease
-
Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome
-
Allele specificity in neurodegenerative olfactory dysfunction
-
Alpha synuclein and crystallin expression in human lens in Parkinson’s disease
-
Alpha-synuclein – super-resolution microscopy reveals potential new role of alpha-synuclein at the pre-synapse
-
Alpha-synuclein aggregates of cardiac sympathetic nerves in synucleinopathies and in neurologically unimpaired subjects. Correlation with sympathetic denervation
-
Alpha-synuclein gene variants may predict neurostimulation outcome
-
Alpha-synuclein in gastric and colonic mucosa in Parkinson’s disease: Limited role as a biomarker
-
Alpha-synuclein levels and dimerization in erythrocytes of Parkinson’s disease patients
-
Alterations in 14-3-3 protein phosphorylation as a biomarker for neurodegeneration
-
Alterations in muscle synergies in early stage Parkinson’s disease
-
Altered brain activation in complex walking conditions in patients with Parkinson’s disease
-
Altered cerebello-thalamo-cortical pathway in Huntington’s disease
-
Altered connectivity within the cerebello-thalamo-cortical network in essential tremor: A resting state fMRI study
-
Altered glutamate response and calcium dynamics in iPSC derived striatal neurons from XDP-patients
-
Altered inter-hemispheric functional coordination in primary blepharospasm
-
Altered resting-state functional interhemispheric connectivity in Parkinson’s disease
-
Alternating hemiplegia of childhood (AHC) as a new presentation of adenylate cyclase 5 (ADCY5)-mutation-associated disease
-
Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3
-
Alternatives for reducing chorea in Huntington disease, a long-term trial (ARC-HD): Updated week 8 results for the switch cohort
-
Ambulatory assessment of tremor
-
Amelioration of αLPHA-synuclein aggregation and motor behavior deficits by apocyanin in intranigral lipopolysaccharide induced animal model of Parkinson’s disease
-
AMP kinase regulates ligand-gated K-ATP channels in substantia nigra dopamine neurons
-
An atypical case of adult-onset, levodopa-responsive, paroxysmal dystonia
-
An elderly patient presenting as pure akinesia with gait freezing (PAGF): Idiopathic aqueductal stenosis-associated hydrocephalus
-
An exuberant cortical γb influences the unmasking and intensity of dyskinesia in 6-OHDA-treated freely-moving rats
-
An innovative international educational network to improve physicians’ current management practices of patients with cervical dystonia and spasticity
-
An international, randomized, sham controlled trial of focused ultrasound thalamotomy for essential tremor
-
An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator
-
An ongoing phase 2, multi-centre, open-label, study of WTX101 in Wilson disease patients – Early observations
-
An open label trial to test the modulation of cerebellar motor pathways in primary orthostatic tremor using rTMS and fMRI
-
An optimized formulation of velocity distribution in digital spiral analysis to differentiate essential tremor and Parkinson’s disease
-
An update on genotype-phenotype correlation in X-linked dystonia-parkinsonism (XDP/DYT3)
-
Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect
-
Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination
-
Analysis of LINGO1 and LINGO2 genes in essential tremor and Parkinson’s disease
-
Analysis of MAPT, GRN and C9orf72 genes in progressive supranuclear palsy, corticobasal syndrome and frontotemporal lobar degeneration in Russian population
-
Analysis of relationships between spinal deformity and walking ability in Parkinson’s disease patients
-
Analysis of temporal gait features extracted from accelerometer-based signals during ambulatory walking in Parkinson’s disease
-
Analysis of the genetic variability in Parkinson’s disease from southern Spain
-
Analysis of the olfactory impairments in PINK1 deficient mice
-
Anhedonia and its correlation with clinical aspects in Parkinson’s disease
-
Anosmia predicts development of more severe motor symptoms including freezing of gait and impaired balance at 2 year follow-up in PD
-
Anti-GAD antibody cerebellar ataxia mimicking multiple system atrophy
-
Anti-LGI1 encephalitis presenting as a progressive supranuclear palsy-like syndrome
-
AntiParkinsonian effects of AG-0029 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson’s disease
-
AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets
-
AntiParkinsonian medication adjustments following deep brain stimulation of subthalamic nucleus in patients with advanced Parkinson’s disease
-
AntiParkinsonian treatment patterns and motor complications among patients with Parkinson´s disease in Estonia
-
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease
-
Anxiety and freezing of gait: A new perspective for early intervention
-
Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder
-
Anxiety in patients with Parkinson’s disease
-
Anxiolytic-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety
-
Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease
-
Apathy phenotype in Parkinson’s disease: Motor and non-motor features
-
APL-130277 is a sublingual film being studied in phase 3 trials to rapidly turn patients ON from OFF episodes by delivering apomorphine via the oral mucosa
-
Apocyanin ameliorates post-stroke movement disorder in rats: Possible role of neurochemical and inflammatory alterations
-
Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA
-
Apomorphine treatment in advanced Parkinson’s disease (PD): Duration of treatment and safety experience in a managed care program in Germany
-
Appendicitis and risk of Parkinson’s disease: A Danish nationwide population-based cohort study
-
Applicability study of a multitask cognitive and motor exercise program for individuals with Parkinson´s disease: The COGWEB CNS Move Program
-
Application and correlates of the PSP quality of life scale
-
Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia
-
Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort
-
Apraclonidine in blepharospasm
-
Apraclonidine in the treatment of ptosis
-
Apraxia in Parkinson’s disease
-
Apraxia of speech as the initial manifestation of progressive supranuclear palsy
-
Aquatic physical therapy: Functional motor skills in people with Parkinson’s disease
-
Are clinical certainty ratings helpful in the diagnosis of Parkinson’s disease?
-
Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?
-
Are limbic and cognitive effects on balance in Parkinson’s disease equal?
-
Are Parkinson’s disease futility studies futile?
-
Are people with Parkinson’s disease living in care homes in the UK underserved? Identifying models of care and barriers to care access
-
Are we speaking the same language? A pilot study to evaluate the agreement in clinical phenotyping of children with cerebral palsy
-
Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia
-
Articulography reveals disturbed speech motor control in ET patients treated with VIM-DBS
-
Assessing the impact of PD motor symptom states on quality of life in patients with advanced Parkinson’s disease
-
Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment
-
Assessment and connection to care: The vital role of the social worker in an interdisciplinary home visit program for advanced Parkinson’s disease patients
-
Assessment of brainstem function with blink reflex variations in Parkinson’s disease
-
Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease
-
Assessment of freezing of gait in Parkinson’s disease patients treated with STN-DBS
-
Assessment of gait dysfunction in patients with Parkinson’s disease and REM behavioral disorder
-
Assessment of humor in Parkinson’s disease and the effect of deep brain stimulation
-
Assessment of malnutrition in patients with Parkinson’s disease
-
Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients
-
Assessment of olfactory dysfunction in Parkinson’s disease with an objective test
-
Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases
-
Assessment of Parkinson’s disease risk loci as DNA methylation quantitative trait loci
-
Assessment of subclinical cerebellar involvement in progressive supranuclear palsy using SUIT based volumetric analysis
-
Assessment of the quality of life of patients with Parkinson’s disease
-
Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease
-
Association analysis of NALCN polymorphisms rs1338041 and rs61973742 in a Chinese population with isolated cervical dystonia
-
Association analysis of SNP rs11868035 in SREBF1 with Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population
-
Association between clinical features and pre- and post-synaptic dopaminergic dysfunction in multiple system atrophy: [18F]-FP-CIT PET and [18F]-FDG PET analyses
-
Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease
-
Association between urine protein/creatinine ratio and cognitive dysfunction in Parkinson’s disease
-
Association of amyotrophic lateral sclerosis with basal ganglia impairment
-
Association of four new candidate genetic variants with Parkinson’s disease in Han Chinese
-
Association of mood and affective disorders with pain in Parkinson’s disease
-
Association of Parkinson’s disease severity and cortical and subcortical cognitive markers
-
Association of Parkinson’s disease with essential tremor
-
Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists
-
Association of UV radiation with Parkinson’s disease incidence: A nationwide French ecologic study
-
Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review
-
Associations between cerebrospinal fluid proteins and cytokines in Parkinson’s disease
-
Astroglia exert a neuro-protective role in Parkinson’s disease by reducing oxygen stress through dopamine-induced activation of the pentose-phosphate pathway
-
Ataxic gait in subjects with essential tremor and thalamic neurostimulation is caused by posteromedial current spread in the (sub)thalamic area
-
Attention and dopamine: Increased distractibility in Parkinson’s disease
-
Attention to action: Common to both conversion (psychogenic) and Parkinsonian (neurogenic) motor speech disorders
-
Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients
-
Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature
-
Atypical presentation of psychogenic movement disorder with jaw-opening dystonia: Two cases reports
-
Auditory cues during obstacle crossing increase gait asymmetry in neurologically health individuals but not in people with Parkinson’s disease
-
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy
-
Augmentation and impulse control disorders in restless legs syndrome – Coexistence or association?
-
Automated assessment of advanced motor Parkinson’s disease; a pilot study of the Parkinson’s KinetiGraph as an objective tool for measurement of motor fluctuations
-
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
-
Automatic event-detection for the neurophysiological evaluation of voluntary and involuntary movements
-
Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease
-
Autophagic modulation by rosuvastatin prevent rotenone induced neurotoxicity as an in vitro model of Parkinson’s disease
-
Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree
-
Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives
-
Axial prominent, delayed onset dystonia in cerebral palsy: Highlights on a distinct phenotype with favorable outcome following deep brain stimulation
2016 International Congress
June 19-23, 2016. Berlin, Germany.